Skip to content

Web-Based Communication Education for Breast Cancer Survivorship Care

Web-Based Communication Education for Breast Cancer Survivorship Care

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03413332
Enrollment
141
Registered
2018-01-29
Start date
2017-04-01
Completion date
2022-03-31
Last updated
2021-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Chinese American Women, Provider-patient Communication, Survivorship Care

Brief summary

This two-phase research plan will develop and test a culturally relevant, web-based patient education program, hereafter known as E-Talkcare. The intervention aims to empower Chinese cancer patients to effectively communicate with different providers in different healthcare settings.

Detailed description

This two-phase study develops and tests the usability and efficacy of a culturally relevant, web-based patient education program, hereafter known as E-Talkcare, in improving Chinese immigrant breast cancer survivors' competence, perceived control, and self-efficacy in cancer care communication (intermediate outcomes), and patient-reported symptoms, adherence to breast cancer survivorship care guidelines, and quality of life (distal outcomes) versus the usual care control arm. In Phase I, community-based participatory research (CBPR) principles will be used to develop the intervention to educate participants about culture and communication by demonstrating how to ask for and verify information with doctors and use personalized symptom reports, and by providing question prompt lists for doctor visits. In Phase II, the intervention will be tested in a pilot randomized control trial (RCT). Using cases from Los Angeles Cancer Surveillance Program, California Cancer Registry, Maryland Cancer Registry, and clinics from California, 118 Chinese immigrant women (diagnosed with stage 0-III breast cancer and 1-3 years post-diagnosis) will be enrolled and randomized to either the E-Talkcare intervention or a usual care control arm. Participants will be interviewed via telephone at baseline (i.e., pre-randomization), 3-, and 6-months post-randomization.

Interventions

OTHERE-Talkcare

Women in the intervention group will receive the E-Talkcare web address, a user name, and a temporary password. The participant will be able to read or listen (through audio narration) to instructions on how to complete the intervention in order, though she can freely navigate between web modules. Each module will have an ever-present indicator (showing users' progress) and a link to for users to continue navigating through modules.We will ask participants to complete the full intervention within 3 months after intervention delivery and then complete a 3-month post-randomization interview (T1). The website will remain open for six months after intervention delivery to allow participants to use QPL if they wish. A 6-month post-randomization interview (T2) will then be administered.

OTHERUsual Care

Survivors randomized to the usual care group will receive care from their doctors as usual, allowing us to compare the intervention against real-world practice to inform next steps. Since we do not know if the intervention will be efficacious, we decided not to provide a delayed intervention to control participants.

Sponsors

Georgetown University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligible Chinese women * ≥ age 18 * foreign-born speaking Mandarin and/or Cantonese, * diagnosed with breast cancer at stage 0, I, II or III, * 1-3 years post-diagnosis and completed primary treatment (surgery, radiation, and chemotherapy); and * no recurrence, and 6) internet access.

Exclusion criteria

* Women with other cancer types are ineligible due to different treatment complications.

Design outcomes

Primary

MeasureTime frameDescription
Medical Communication Competence Scale6 months16 items to assess information provision, seeking, and verifying; α=.80-.89.
Assessment of Patient Experiences of Cancer Care6 months10-item patient-reported communication quality with follow-up care doctors; α=.75 in Chinese
Decision-making Participation Self-efficacy Scale6 months5-item measure of patient's efficacy in engaging in medical communication; α=.89 in Chinese
Perceived Personal Control Scale6 months4-item measure of patients' perceived personal control over breast cancer; α=.71 in Chinese

Secondary

MeasureTime frameDescription
PROMIS Physical Function6 months8 items (e.g., carry heavy objects, kneeling, doing 2-hour labor work); α=.90
PROMIS Anxiety6 months7 items (e.g., felt anxious, nervous, fearful, tense); α=.90
PROMIS Fatigue6 months6 items (e.g., felt tired, exhausted, limited at work); α=.97
Side/late Effect Assessments6 months31-item measure of patient-reported side/late effects from breast cancer treatment
Adherence to Breast Care Guidelines6 months26 yes-no items: receiving breast cancer follow-up care recommendations from doctors
PROMIS Depression6 months8 items (e.g., felt helpless, depressed, unhappy, hopeless); α=.90
PROMIS Sleep Disturbance6 months6 items (e.g., sleep not steady, unsatisfied, hard to fall asleep); α=.98
PROMIS Pain Interference6 months6 items (e.g., affecting ability to focus, interact with others, run errands); α=.95
PROMIS Cognitive Function6 months6 items (e.g., had trouble concentrating, slow thinking, hard to concentrate); α=.95

Countries

United States

Contacts

Primary ContactJudy Wang, Ph.D.
jw235@georgetown.edu202-687-6306
Backup ContactJiayan Gu, MSPH
jg1829@georgetown.edu202-687-8007

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026